Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (272)	2/12/1999 12:57:00 PM
From: Rod Gilchrist	Read Replies (1) \| Respond to of 337

Business Week article is the "Science and Technology" section of the magazine, a page and two thirds in all. Title is "Outsmarting the Virus". Big picture of John Stevens (VGIN CEO) (2/3 page wide, 1/2 page high), shared 50/50 with big image of a video display and some neat reflections off a couple of microcells. Label is "Contender: John Stevens of Toronto startup Visible Genetics". Article is about HIV 'resistance testing'. Quote in the first paragraph "Drug resistance is a big problem, and its not going away" from John Mellors (a very big name in HIV research). Second paragraph includes "Such individually tailored drug regimes represent a whole new kind of medicine" says John Stevens... Sidebar: "To test or not to test" gives pros and cons. A pretty clear balance to pro with mostly 'not yet knowns' on the con side. Article is a well written, well thought out, informed discussion of resistance testing for HIV. Full marks to John Carey of Business Week. Best press I've seen so far. - Rod